Build the future of personalized medicine together.
BioTwin partners with healthcare systems, pharma, research institutions, and investors to deploy validated clinical decision support technology powered by virtual twin methodology.
Clinical partnerships are limited by jurisdiction. BioTwin clinical cancer screening decision assistance is available only in authorized UAE clinical settings unless and until additional local authorizations are granted.
Primary care, hospitals, wellness centers
Deploy clinical decision support tools for preventive care, risk stratification, and longitudinal clinical development and follow-up workflows. BioTwin augments physician judgment with Bio-Signature insights while clinical authority remains fully with the treating provider.
Clinical partnerships are limited by jurisdiction. BioTwin clinical cancer screening decision assistance is available only in authorized UAE clinical settings unless and until additional local authorizations are granted.
What partners receive:
- Clinical pilots with structured validation
- Multi-domain screening pathways
- Patient retention and engagement
- Physician-led decision support
Drug development, RWE, endpoint prediction
Leverage virtual twins for patient stratification, clinical trial optimization, and real-world evidence generation. BioTwin models identify responders before enrollment and predict clinical outcomes.
What partners receive:
- Patient selection and enrichment
- Predictive endpoint modeling
- Longitudinal clinical development and follow-up workflows
- Regulatory-grade evidence
Academic hospitals, think tanks, NIH
Co-develop virtual twin methodology through joint research, data collaborations, and peer-reviewed publications. BioTwin works with academic partners to advance the science of longitudinal personalized health.
What partners receive:
- Co-authorship pathways
- Federated multi-site analysis
- Technology transfer licensing
- Grant collaboration
How to partner with BioTwin
A structured pathway from exploratory call to commercial deployment. Typical timeline: 3 to 6 months for pilot launch.
Exploratory call
1-hour strategy session to assess fit and objectives
Due diligence
Technical assessment, data review, and regulatory alignment
Pilot design
Define scope, KPIs, timeline, and success metrics
IRB & governance
Joint ethics review, consent framework, data agreements
Deployment
Pilot launch, training, and ongoing support
Scale
Validation outcomes, commercial terms, and expansion
Research ethics & governance
All BioTwin research and partnerships adhere to established ethical and regulatory standards. IRB approval, informed consent, and formal data governance agreements are required for all collaborations. Patient privacy, auditability, and data security are foundational.
Ready to start a partnership conversation?
Submit your partnership inquiry. The BioTwin team will review and respond within 48 hours.
One account across BioTwin and TwinMe. No second sign-up required.